Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
64.63
-1.22 (-1.85%)
At close: Nov 26, 2025, 4:00 PM EST
63.35
-1.28 (-1.98%)
After-hours: Nov 26, 2025, 6:39 PM EST
Bio-Techne Revenue
Bio-Techne had revenue of $286.56M in the quarter ending September 30, 2025, a decrease of -1.00%. This brings the company's revenue in the last twelve months to $1.22B, up 3.85% year-over-year. In the fiscal year ending June 30, 2025, Bio-Techne had annual revenue of $1.22B with 5.23% growth.
Revenue (ttm)
$1.22B
Revenue Growth
+3.85%
P/S Ratio
8.33
Revenue / Employee
$392,494
Employees
3,100
Market Cap
10.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.22B | 60.58M | 5.23% |
| Jun 30, 2024 | 1.16B | 22.36M | 1.97% |
| Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
| Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
| Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TECH News
- 2 days ago - Bio-Techne to Present at Upcoming Investor Conferences - PRNewsWire
- 7 days ago - Bio-Techne Corporation (TECH) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 9 days ago - Bio-Techne Corporation (TECH) Presents at Stephens Annual Investment Conference 2025 Transcript - Seeking Alpha
- 9 days ago - Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio - PRNewsWire
- 16 days ago - Bio-Techne Corporation (TECH) Presents at Stifel 2025 Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Bio-Techne Corporation (TECH) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Bio-Techne Corporation (TECH) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Bio-Techne misses quarterly sales estimates on weak biotech demand - Reuters